Background-We sought to clarify, using functional and biological approaches, the role of epoxyeicosatrienoic acids, nitric oxide (NO)/reactive oxygen species balance, and endothelin-1 in conduit artery endothelial dysfunction during essential hypertension. Methods and Results-Radial artery diameter and mean wall shear stress were determined in 28 untreated patients with essential hypertension and 30 normotensive control subjects during endothelium-dependent flow-mediated dilatation induced by hand skin heating. The role of epoxyeicosatrienoic acids and NO was assessed with the brachial infusion of inhibitors of cytochrome P450 epoxygenases (fluconazole) and NO synthase (N G -monomethyl-L-arginine [L-NMMA]). Compared with controls, hypertensive patients exhibited a decreased flow-mediated dilatation in response to postischemic hyperemia as well as to heating, as shown by the lesser slope of their diameter-shear stress relationship.
T he endothelium plays a crucial role in controlling vascular tone and homeostasis through the release of vasoactive factors. 1, 2 In essential hypertension, endothelial dysfunction is present in both resistance and conduit arteries and constitutes an early independent predictor of cardiovascular events. 2, 3 Moreover, it was prospectively shown that the normalization of blood pressure with the use of conventional antihypertensive drugs is associated with a greater reduction in the occurrence of cardiovascular events when conduit artery endothelial function is restored. 3 Therefore, the restoration of conduit artery endothelial function has emerged as a primary target to limit cardiovascular morbidity and mortality in patients with essential hypertension.
Clinical Perspective on p 1275
However, the mechanisms of endothelial dysfunction, although largely investigated in resistance arteries, 4 -8 have been poorly documented at the level of the conduit arteries in human hypertension. In fact, to our knowledge, the role of a decrease in nitric oxide (NO) availability has only been reported in 1 study. 9 In addition, the evolution of the epoxyeicosatrienoic acid (EET) pathway has never been explored. This is particularly important because EETs, which are synthesized by endothelial cytochrome P450 epoxygenases, share with NO many cardiovascular protective properties, contributing notably to the regulation of vascular tone and remodeling. In addition, increasing experimental evidence suggests that a decrease in EET availability is involved in the pathophysiology of end-organ damage in arterial hypertension. 2, 10 Furthermore, a role for the vasoconstrictor endothelin-1 (ET-1) and reactive oxygen species (ROS), which inactivate NO, in the endothelial dysfunction associated with arterial hypertension remains to be clarified at the level of the conduit arteries in humans.
In this context, the use of a sustained hyperemic stimulation induced by the hand skin heating method may be useful. 11 Indeed, we demonstrated in healthy volunteers by combining this method with functional approaches based on the local inhibition of cytochrome P450 epoxygenases and NO synthase that both pathways contribute to the regulation of conduit artery flow-mediated dilatation. 11 Moreover, because of the sustained and stable increase in blood flow, it is possible to draw local blood samples during heating and thus to putatively perform the biological identification of the endothelial factors released. 11 In this context, the present study was designed to compare, with the use of functional and biological approaches, the role of EETs, NO/ROS balance, and ET-1 during endotheliumdependent flow-mediated dilatation in patients with essential hypertension and normotensive control subjects.
Methods

Subjects
The study was performed in a total of 58 subjects. All subjects were nonsmokers, must not have received hormone replacement therapies or statins for the last 6 months, and did not receive any medication at the time of the study. 12 Subjects with cardiac and/or cerebrovascular ischemic disease, heart failure, impaired renal function (estimated glomerular filtration rate Ͻ60 mL/min per 1.73 m 2 according to the Cockcroft-Gault equation), or other major pathologies were excluded from the study. Twenty-eight untreated patients with essential hypertension were recruited from general practitioners of the local clinical research network if supine systolic and diastolic blood pressures measured after 10 minutes of rest were consistently found to be Ն140/90 mm Hg 3 times at 1-to 2-week intervals. Secondary forms of hypertension were excluded by routine diagnostic procedures. Patients were enrolled if never treated (nϭ19) or reporting a medical history of discontinued pharmacological antihypertensive treatment interrupted for at least 3 months before the day of inclusion to exclude possible remnant effects of the drugs on endothelial function (nϭ9). Moreover, 30 volunteers frequency-matched for major vascular risk factors with the hypertensive patients (Table) were recruited by the Centre d'Investigation Clinique-Institut National de la Santé et de la Recherche Médicale 0204 and the Department of Pharmacology of Rouen University Hospital and were deemed healthy on the basis of the absence of familial history of essential hypertension and systolic and diastolic blood pressure values Ͻ140/90 mm Hg, as well as complete medical exami-nation and routine laboratory tests. On the day of inclusion, systolic and diastolic blood pressures were measured after 10 minutes of rest on the dominant arm by means of a brachial cuff oscillometric device (Omron HEM-705CP) 3 times at 5-minute intervals. The study was approved by the local ethics committee (Committee for the Protection of Persons of Normandy), and all participants gave written informed consent. The study was conducted according to the Principles of Good Clinical Practice and the Declaration of Helsinki. The study was registered at https://www.eudract.ema.europa.eu under the unique identifier RCB2007-A001-10-53.
General Procedure
Measurements were performed in the morning while subjects were in a supine position in a quiet air-conditioned room maintained at a constant temperature (22°C to 24°C). Radial internal diameter, blood flow, and digital arterial pressure were measured continuously on the nondominant arm with a high-precision echo tracking device coupled to a Doppler system (NIUS 02, Asulab) and a finger photoplethysmograph (Finapres System, Ohmeda). 11
Assessment of Conduit Artery Endothelial Dysfunction in Essential Hypertension Using Postischemic Hyperemia and Hand Skin Heating
Peripheral conduit artery endothelial dysfunction has been demonstrated in essential hypertension with the classic method of postischemic hyperemia 9 but not with the hand skin heating method. Therefore, radial artery endothelial function was assessed in 12 hypertensive patients and 12 control subjects with the use of both methods and by measuring endothelium-independent dilatation.
Postischemic Hyperemia
An arterial occlusion cuff was placed on the wrist, was inflated 50 mm Hg above systolic blood pressure for 10 minutes, and was deflated to allow postischemic hyperemia with the continuous measurements of all parameters. Postischemic hyperemia was characterized by the peak flow (maximal increase in blood flow) and the duration of the increase in flow (t1/2ϭtime elapsing between peak hyperemia and return to 50% of this peak).
Hand Skin Heating
The hand skin temperature was modified by use of a water-filled thermo-controlled device (Polystat 1, Bioblock Scientific). The hand was introduced in the thermo-controlled tank by use of a thin watertight glove fixed to the device. The device was then filled with water, and the temperature was fixed to 34°C for 20 minutes. Then hand skin heating was performed by gradually increasing the water temperature from 34°C to 37°C, 40°C, and 44°C, with each level of temperature maintained for 7 minutes. Total blood viscosity was measured with a cone-plate viscometer (Ex100 CTB, Brookfield) at a shear rate of 241 s Ϫ1 at 37°C. 11 From the individual values of radial artery diameter (d), flow (Q), and total blood viscosity (), the mean arterial wall shear stress was calculated on the basis of a poiseuillean model {ie, ϭ[(4 Q)/(r 3 ), (rϭd/2)]}, and the diameter-shear stress relationships were constructed in hypertensive patients and control subjects to compare these 2 groups at the same level of stimulus. 11
Endothelium-Independent Dilatation
Radial artery endothelium-independent dilatation was assessed with the use of 0.3 mg sublingual glyceryl trinitrate.
Evolution of NO, EETs, ET-1, and ROS Pathways During Heating-Induced Flow-Mediated Dilatation in Essential Hypertension
The role of NO, EETs, ET-1, and ROS during heating was assessed in 16 hypertensive patients and 18 control subjects by functional and biological approaches.
Functional Approach
The forearm volume of each volunteer was measured by the water displacement method to adjust the doses of the pharmacological agents to be infused. A 27-gauge needle was inserted under local anesthesia (1% lidocaine) into the brachial artery of the nondominant arm to permit infusion of saline (0.9%) and pharmacological agents at a constant rate (1 mL/min) with the use of dual programmable syringe pumps (Vial Program 2, Becton Dickinson). Oral aspirin (500 mg; BMS Laboratory) was administered to block the production of vasomotor prostanoids. 11 To assess the functional role of the EET pathway in radial artery flow-mediated dilatation, heating was performed during the infusion of saline and the inhibitor of cytochrome P450 epoxygenases fluconazole (0.4 -1.6 mol/min per liter; Pfizer Holding). 11 To assess the role of the NO pathway and whether a contribution of the EET pathway may be unmasked under conditions of reduced NO availability, heating was performed during the infusion of saline, the NO synthase inhibitor N G -monomethyl-Larginine (L-NMMA) (8 -20 mol/min per liter; Bachem), and fluconazole associated with L-NMMA. 11 Moreover, endotheliumindependent dilatation in response to sodium nitroprusside (from 5-20 nmol/min per liter; 3 minutes each dose) was assessed. 11
Biological Approach
In addition to the functional approach, a 4F catheter was inserted into the distal portion of the antecubital vein of the infused arm, when accessible, allowing blood sampling in the venous return at 34°C and 44°C. 11 Blood sampling was performed in the absence and in the presence of fluconazole for the quantification of EET plasma level by gas chromatography/mass spectrometry with negative-ion chemical ionization, 13 as well as in the absence and in the presence of L-NMMA for the quantification of nitrite plasma level, used as indicator of NO bioavailability, by a triiodide/ozone-based chemiluminescence assay. 14 Moreover, ET-1 plasma levels were quantified with the use of a human ET-1 EIA kit, 15 and whole blood level of ROS was quantified by electron paramagnetic resonance spectroscopy (Miniscope MS-200, Magnettech). 11 An expanded description of the biological approach is available in the online-only Data Supplement.
Statistical Analysis
Statistics were performed with the SYSTAT package (SYSTAT 8.0; SPSS). Continuous variables are presented as meanϮSD in the text and as meanϮSEM in the figures, unless indicated differently. Qualitative variables are presented as absolute and relative frequencies.
Normality of data was assessed with the Shapiro-Wilk test, and a logarithmic transformation was used to normalize distributions, when appropriate. Differences between groups were assessed by Fisher exact test for categorical variables and by 2-sample t test for continuous variables. Analysis of flow-mediated dilatation induced by postischemic hyperemia was repeated with ANOVA with group as factor and with peak flow and duration of the increase in flow as covariates. Differences between groups for the diameter-shear stress relationship were assessed by ANOVA with the use of a generalized linear model with group, shear stress, and subject as factors. Differences between the effects of the inhibitors on the diametershear stress relationship were assessed within group by ANOVA with the use of a generalized linear model with inhibitor, shear stress, and subject as factors followed, in case of significance, by a Tukey test for post hoc pairwise comparisons. Differences within and between groups for the reduction in the magnitude of flow-mediated dilatation obtained with the inhibitors were assessed by ANOVA with the use of a generalized linear model with group, inhibitor, and subject as factors followed, in case of significance, by a Tukey test for post hoc pairwise comparisons. In addition, the impact of blood pressure levels on the magnitude of flow-mediated dilatation during saline infusion and on the absolute change in flow-mediated dilatation induced by fluconazole and L-NMMA was assessed by comparing these variables in the quartiles of diastolic blood pressure in the whole population with a Kruskal-Wallis test followed, in case of significance, by a Dunn test for post hoc pairwise comparisons. Differences between biological markers levels at 34°C and 44°C were assessed within groups under each inhibitor condition with a paired t test. Differences within and between groups for the variations of biological markers levels between 34°C and 44°C were assessed by ANOVA with a generalized linear model with group, inhibitor, and subject as factors followed, in case of significance, by a Tukey test for post hoc pairwise comparisons. Spearman rank correlation coefficient (r s ) was calculated to assess the correlation between diastolic blood pressure obtained the day of inclusion and functional and biological variables. Finally, Pearson correlation analysis was performed to determine the linear relationship between the variations in biological markers levels and the magnitude of flow-mediated dilation during heating. A value of PՅ0.05 was considered statistically significant.
Results
There was no significant difference between hypertensive patients and normotensive controls for demographic and biological characteristics except for higher systolic and diastolic blood pressures and higher heart rate in hypertensive patients compared with normotensive controls (Table) . In addition, the basal radial artery diameter, blood flow, and mean wall shear stress were similar in patients and controls.
Assessment of Conduit Artery Endothelial Dysfunction in Essential Hypertension With the Use of Postischemic Hyperemia and Hand Skin Heating
Peak flow ( Figure 1A) was not significantly different, but the duration of the increase in flow ( Figure 1B ) and the magnitude of radial artery flow-mediated dilatation ( Figure 1C ) obtained with postischemic hyperemia were reduced in hy-pertensive patients (nϭ12) compared with normotensive controls (nϭ12). The difference between groups in the magnitude of flow-mediated dilatation remained significant after adjustment for peak flow and duration of the increase in flow (PϽ0.001).
There was a downward shift of the radial artery diametermean wall shear stress relationship obtained during hand skin heating in hypertensive patients (nϭ12) compared with normotensive controls (nϭ12; Figure 1D ). Thus, the magnitude of radial artery flow-mediated dilatation (from 34°to 44°C) was reduced in patients (0.373Ϯ0.132 mm) compared with controls (0.484Ϯ0.104 mm; Pϭ0.03). The radial artery endothelium-independent dilatation in response to glyceryl trinitrate was not significantly different between groups ( Figure 1E ).
Evolution of NO and EET Pathways During Heating-Induced Flow-Mediated Dilatation in Essential Hypertension
Functional Approach
Compared with saline, fluconazole induced a downward shift of the radial artery diameter-mean wall shear stress relationship in normotensive controls (nϭ14) but not in hypertensive patients (nϭ11; Figure 2A ). Thus, the magnitude of radial artery flow-mediated dilatation (from 34°to 44°C) was reduced by fluconazole in controls but not in patients ( Figure 2B ).
Compared with saline, L-NMMA and, to a larger extent, L-NMMAϩfluconazole induced a downward shift of the diameter-shear stress relationship in normotensive controls (nϭ14; Figure 3A) . Thus, the magnitude of radial artery flow-mediated dilatation was reduced by L-NMMA and, to a larger extent, by L-NMMAϩfluconazole in controls ( Figure  3B ). In contrast, L-NMMA and L-NMMAϩfluconazole induced a similar downward shift of the diameter-shear stress relationship in hypertensive patients (nϭ13). Thus, the magnitude of radial artery flow-mediated dilatation was reduced similarly by L-NMMA and L-NMMAϩfluconazole in patients. Moreover, the decrease in flow-mediated dilatation induced by L-NMMA was lesser in patients than in controls.
In the entire population, there was a significant decrease in the magnitude of flow-mediated dilatation under saline infusion as well as in the absolute change in flow-mediated dilatation induced by fluconazole and L-NMMA with the increase in diastolic blood pressure ( Figure 4A through 4C) .
The radial artery endothelium-independent dilatation in response to sodium nitroprusside was not significantly differ- 
Biological Approach
The basal EET plasma level was not significantly different in normotensive controls (12.8Ϯ4.5 ng/mL; nϭ9) and in hypertensive patients (13.9Ϯ4.0 ng/mL; nϭ9; Pϭ0.27). However, hand skin heating induced an increase in local plasma EET level only in controls ( Figure 5A ). This increase was reduced but not abolished by fluconazole. In the entire population, the variation in plasma EET level during heating was inversely correlated with diastolic blood pressure (r s ϭϪ0.61, Pϭ0.009).
The basal nitrite plasma level was lower in hypertensive patients (140Ϯ25 nmol/L; nϭ7) than in normotensive controls (176Ϯ30 nmol/L; nϭ7; Pϭ0.049). Heating induced an increase in local plasma nitrite level in both groups, but this increase was lesser in hypertensive patients ( Figure 5B ). The increase in nitrite was abolished in both groups by L-NMMA. In the entire population, the variation in plasma nitrite level during heating was inversely correlated with diastolic blood pressure (r s ϭϪ0.71, Pϭ0.013).
The basal ET-1 plasma level was not significantly different under our experimental conditions in normotensive controls (2.5Ϯ0.8 pmol/L; nϭ9) and in hypertensive patients (3.2Ϯ1.0 pmol/L; nϭ9; Pϭ0.13), but hand skin heating induced a decrease in local plasma ET-1 level in controls but not in patients ( Figure 6A ). In the entire population, there was a significant decrease in the variation of plasma ET-1 during heating with the increase in diastolic blood pressure (r s ϭ 0.65, Pϭ0.009; Figure 6B ). Moreover, the decrease in ET-1 during heating in normotensive controls was not significantly affected by fluconazole (nϭ5) or by L-NMMA (nϭ5; Figure  IIA and IIB in the online-only Data Supplement).
The basal ROS blood level was not significantly different between normotensive controls (34.6Ϯ6.9 mol/L; nϭ7) and Heating induced an increase in blood ROS level in both groups, but this increase was higher in hypertensive patients (Figure 7) . The increase in ROS was reduced by L-NMMA in patients but not in controls and was abolished in both groups by L-NMMAϩfluconazole. Moreover, the increase in ROS during heating was similarly reduced by fluconazole alone in normotensive controls and in hypertensive patients ( Figure III in the online-only Data Supplement).
Finally, the magnitude of radial artery flow-mediated dilatation induced by heating during saline infusion in the population of hypertensive patients and normotensive controls was positively correlated with nitrite variation (nϭ14; rϭ0.65, Pϭ0.008) and negatively correlated with the variations of ET-1 (nϭ18; rϭϪ0.47, Pϭ0.046) and ROS but did not reach statistical significance (nϭ14; rϭϪ0.45, Pϭ0.08; Figure IVA through IVC in the online-only Data Supplement). In addition, the magnitude of flow-mediated dilatation was negatively correlated with EET variation during heating but only in normotensive controls (nϭ9; rϭϪ0.63, Pϭ0.055; Figure IVD in the online-only Data Supplement).
Discussion
The major finding of this study is that the decrease in flow-mediated dilatation of peripheral conduit arteries in patients with essential hypertension is due to an imbalance between endothelium-derived relaxing and constricting factors, characterized by the abrogation of the EET pathway, an altered NO/ROS balance, and an associated absence of adaptation of the ET-1 pathway to flow increase.
First, we validated hand skin heating as a useful tool to detect conduit artery endothelial dysfunction in patients with essential hypertension. Indeed, we observed that the radial artery flow-mediated dilatation was decreased in patients in response to heating as well as in response to the more commonly used method of postischemic hyperemia, without modification in the smooth muscle cell reactivity. Interestingly, although peak flow was preserved, we noticed that there was a decrease in the duration of the increase in flow during postischemic hyperemia in our patients. 16 As stressed previously, this may be due to an imbalance between vasoconstrictor and vasodilator influences and thus may reflect the presence of an arteriolar endothelial dysfunction shortening the time to return to baseline tone and flow. 17 Although the difference between groups for flow-mediated dilatation persists after statistical adjustment, this reduced hyperemia probably contributed to the decrease in the endothelial response. 18 In this context, the downward shift of the diametershear stress relationship obtained in hypertensive patients during heating compared with controls confirms, by directly taking into account the flow stimulus, the presence of this endothelial dysfunction.
In regard to the NO pathway, we confirmed in our normotensive controls the physiological role of NO in the regulation of conduit artery flow-mediated dilatation. 11, 17 Indeed, the pharmacological inhibition of NO synthase with L-NMMA was associated with a downward shift of the diameter-shear stress relationship during heating. Accordingly, the local plasma nitrite level increased during heating under saline infusion, as shown previously during postischemic hyperemia, 19 but we also demonstrated that these nitrites originated from NO produced by NO synthase because the nitrite level was no longer increased in the presence of L-NMMA. In hypertensive patients, there was a lesser basal nitrite plasma concentration compared with control subjects, confirming biologically the decrease in basal NO availability during this disease. 4, 5, 9 In this respect, previous data have demonstrated an inverse correlation between nitrite level and the number of cardiovascular risk factors, including hyper-tension. 20 Moreover, L-NMMA reduced flow-mediated dilatation and local plasma nitrite level also increased during heating in patients, but these effects were significantly less marked than in control subjects, showing that an alteration in the NO pathway contributes to the endothelial dysfunction of conduit arteries during essential hypertension. These results are in agreement with a previous functional study demonstrating the absence of an inhibitory effect of L-NMMA on flow-mediated dilatation in patients with essential hypertension but in response to less sustained stimulation induced by postischemic hyperemia. 9 Furthermore, using the biological approach, we observed, in accordance with our previous results obtained in healthy subjects, that ROS increased during heating in both studied groups. 11 However, this increase was higher in patients than in controls, although basal levels were similar, and this between-group difference was abolished by L-NMMA. These results strongly support the hypothesis that increased ROS production originating from uncoupled NO synthase contributed to the endothelial dysfunction of conduit arteries in our patients, in accordance with several animal observations. 21 Conversely, a role for cytochrome P450 epoxygenases in this increased ROS production, a mechanism contributing to the endothelial dysfunction of resistance arteries in patients with coronary artery disease, 22 appears not to be involved. In fact, fluconazole either alone or associated with L-NMMA similarly reduced ROS production in both groups. Moreover, this last result is in accordance with our previously reported data suggesting that a physiological production of ROS by a cytochrome P450 -dependent mechanism occurs in cutaneous resistance arteries to limit the skin arteriolar dilatation during heating. 11 In regard to the EET pathway, we confirmed in controls the physiological role of cytochrome P450 epoxygenases in the regulation of conduit artery flow-mediated dilatation, 11, 23 as illustrated by the downward shift of the diameter-shear stress relationship induced by fluconazole during heating, infused either alone or in the presence of L-NMMA. Moreover, we provided for the first time in humans in vivo strong evidence that EETs are the factors produced by cytochrome P450 epoxygenases mediating this response. Indeed, we observed that the local EET plasma concentration increased during the flow stimulation and that this increase was impaired by fluconazole. Interestingly, the increase in EET level was reduced but not abolished by fluconazole, suggesting, as shown in animals, the presence of an intracellular storage form of EETs into phospholipids, which can be liberated on cell activation independently of cytochrome P450 epoxygenase activity. 24 In hypertensive patients, the basal EET plasma level was similar to that of control subjects according to 1 reported study, which demonstrated with the use of biological quantification that the alteration in basal EET availability can only be significantly detected in renovascular hypertensive patients. 25 However, we no longer observed in patients a reduction in flow-mediated dilatation with fluconazole alone or even associated with L-NMMA or an increase in the local EET plasma level during heating, demonstrating for the first time that, in addition to NO, an impairment in EET pathway contributes to the conduit artery endothelial dysfunction during essential hypertension. This impairment in EET pathway during arterial hypertension has been suggested previously from animal experiments and notably may be due to an increased degradation of EETs by soluble epoxide hydrolase. 2, 10, 26 Conversely, an increased role of cytochrome P450 epoxygenases in endothelium-dependent dilatation was reported at the level of forearm resistance arteries in patients with essential hypertension compared with normotensive controls, which compensates for the decrease in NO availability. 8 Whether these discrepancies are related to differences in the vascular beds studied or to the grade and/or duration of hypertension of patients remains to be investigated.
Furthermore, in accordance with most of the previous studies, 27, 28 we observed a slightly higher basal ET-1 plasma level in our hypertensive patients compared with controls, although this was not significant under our experimental conditions. However, as stressed previously, 28 because endothelium-derived ET-1 has a predominantly paracrine action, its basal plasma level does not necessarily represent the degree of activation of the endothelin system. Most interesting, we observed that plasma ET-1 availability decreases during flow stimulation in controls but not in patients. It must be stressed that the studies evaluating the role of shear stress in the modulation of ET-1 release by the endothelium are controversial and are probably influenced by experimental conditions. 29 In fact, the level, duration, and steady or pulsatile application of shear stress as well as the cell type and species studied may influence the results. 29 Nonetheless, 1 study has demonstrated in vivo in healthy volunteers, with the use of local infusion of a blocker of the ET-1 type A receptor, that ET-1 acutely mediates the radial artery constriction associated with conditions of reduced flow induced by distal ischemia. 30 This result, suggesting an increased availability of ET-1 during conditions of reduced shear stress, supports our hypothesis (ie, a decreased availability of ET-1 with increased shear stress). Importantly, this mechanism appears to be lost in hypertensive patients and thus could contribute to aggravate the conduit artery endothelial dysfunction by exacerbating the vasoconstrictor influence of ET-1. Thus, the administration of newly developed ET-1 receptor antagonists, which have recently been shown to improve blood pressure control in resistant hypertension, 31 may also be useful to prevent residual conduit artery endothelial dysfunction during essential hypertension, as shown in forearm arterioles. 7 Furthermore, this absence of decrease in ET-1 during flow stimulation in patients may be related to the decrease in the availability of NO, which can acutely impair ET-1 release. 32 However, NO-independent mechanisms directly mediated by shear stress are probably involved, as observed previously in primary culture of human umbilical veins, 33 because the inhibition of NO synthase in our healthy controls did not abolish the decrease in ET-1 variation during heating. In the same way, the decreased availability of EETs is probably not involved because the inhibition of cytochrome P450 epoxygenases by fluconazole did not affect ET-1 variation in controls. Additional experiments are necessary to explore the interplay between EETs and ET-1 pathways, as stressed previously with the use of ET-1 receptor antagonists and/or infusion of synthetic EET analogues, which are currently under development but not available for human use.
Finally, in addition to demonstrating the presence of these alterations in EETs, NO, and ET-1 pathways in patients with essential hypertension at the level of the conduit arteries, our results show, in the entire population studied, a progressive impairment of these pathways, with the increase in blood pressure levels thus contributing to reduce endotheliumdependent flow-mediated dilatation.
In conclusion, our results demonstrate that an impaired role of EETs contributes, with an alteration in NO and ET-1 pathways, to conduit artery endothelial dysfunction in essential hypertension. In this context, restoring the EET pathway may be useful to prevent conduit artery endothelial dysfunction during essential hypertension; this thus represents a new therapeutic target that may be useful to improve the cardiovascular prognosis in patients.
Study Limitations
Average levels of total and low-density lipoprotein cholesterol were borderline high according to American Heart Association guidelines in our study participants. However, these levels were similar between groups and were associated with normal values of high-density lipoprotein cholesterol, thus probably not affecting sustained conduit artery flowmediated dilatation. 34 Furthermore, blood sampling was performed in the venous return, and thus measured factors may originate from distal vascular compartments. However, the magnitude of flow-mediated dilatation was positively correlated with nitrite variation and negatively correlated with ET-1 and ROS variations, showing that a significant part of these factors originates from the studied conduit artery. 19 Finally, in an unexpected way, there was a negative correlation between the radial artery dilatation and EET variation in healthy subjects. Although dedicated experiments are warranted, this result may reflect a compensatory increased release of EETs, which may help to maintain the vasodilator function in subjects with incipient alteration in endothelial function, in particular during aging, whereas this mechanism is lost in hypertensive patients. Accordingly, we noticed that
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the decrease in flow-mediated dilatation obtained with fluconazole was 25% higher in the subjects explored in the present study (Ϸ125 m) than in the younger healthy subjects (mean age of 25 years) previously explored (Ϸ100 m), whereas, at the same time, the magnitude of the dilatory response decreased by 20% in older subjects (620 versus 500 m). 11 Furthermore, we cannot exclude that fluconazole affected pathways other than EETs. However, this appears unlikely under our experimental conditions because fluconazole reduced flow-mediated dilatation even when infused with L-NMMA and did not affect the decrease in plasma ET-1 during heating in control subjects, suggesting the absence of effects on NO and ET-1 pathways.
